Back to top
more

Chemours (CC)

(Real Time Quote from BATS)

$24.52 USD

24.52
331,942

+0.78 (3.29%)

Updated Jun 12, 2024 01:23 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (92 out of 249)

Industry: Chemical - Diversified

Better trading starts here.

Zacks News

Are Investors Undervaluing Chemours (CC) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Chemours (CC) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for Chemours (CC) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Chemours (CC) Surpasses Q1 Earnings Estimates

Chemours (CC) delivered earnings and revenue surprises of 58.06% and 0.87%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Methanex (MEOH) Q1 Earnings and Revenues Top Estimates

Methanex (MEOH) delivered earnings and revenue surprises of 20.65% and 6.46%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Northern Technologies (NTIC) Misses Q2 Earnings and Revenue Estimates

Northern Technologies (NTIC) delivered earnings and revenue surprises of -44.44% and 10.44%, respectively, for the quarter ended February 2023. Do the numbers hold clues to what lies ahead for the stock?

Here's Why You Should Hold Onto Chemours (CC) Stock for Now

While Chemours (CC) is exposed to headwinds from higher raw material costs, it gains on healthy Opteon demand and its pricing actions.

Chemours (CC) Posts Break-Even Q4 Earnings, Sales Miss

Chemours (CC) gains from increased prices across its segments amid headwinds from higher input cost inflation, adverse currency movements and soft demand in Europe & Asia in Q4.

Chemours (CC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Chemours (CC) give a sense of how the business performed in the quarter ended December 2022, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Chemours (CC) Reports Break-Even Earnings for Q4

Chemours (CC) delivered earnings and revenue surprises of -100% and 5.93%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

FMC (FMC) Surpasses Q4 Earnings and Revenue Estimates

FMC (FMC) delivered earnings and revenue surprises of 2.16% and 7.86%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Chemours (CC) to Report a Decline in Earnings: What to Look Out for

Chemours (CC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Implied Volatility Surging for Chemours (CC) Stock Options

Investors need to pay close attention to Chemours (CC) stock based on the movements in the options market lately.

Albemarle (ALB) Up 0.3% Since Last Earnings Report: Can It Continue?

Albemarle (ALB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Chemours (CC) Gains on Opteon Demand Amid Input Cost Woes

While Chemours (CC) is exposed to headwinds from higher raw material costs, it gains on healthy Opteon demand, strong execution and its cost-reduction and pricing actions.

Chemours (CC) Earnings and Revenues Top Estimates in Q3

Higher prices contribute favorably to Chemours' (CC) top line growth in the third quarter.

New Strong Sell Stocks for October 26th

HES, JRVR and CC have been added to the Zacks Rank #5 (Strong Sell) List on October 26, 2022.

Chemours (CC) Surpasses Q3 Earnings and Revenue Estimates

Chemours (CC) delivered earnings and revenue surprises of 6.90% and 0.31%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Chemours (CC) Dips More Than Broader Markets: What You Should Know

Chemours (CC) closed at $28.77 in the latest trading session, marking a -1.34% move from the prior day.

Earnings Preview: Methanex (MEOH) Q3 Earnings Expected to Decline

Methanex (MEOH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Chemours (CC) to Post Q3 Earnings: What's in the Offing?

While Chemours (CC) is likely to have benefited from healthy demand and pricing actions, raw material inflation and ore logistics constraints are expected to have affected its performance.

Earnings Preview: Chemours (CC) Q3 Earnings Expected to Decline

Chemours (CC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Chemours (CC) Dips More Than Broader Markets: What You Should Know

Chemours (CC) closed the most recent trading day at $26.53, moving -1.38% from the previous trading session.

Chemours (CC) Gains But Lags Market: What You Should Know

Chemours (CC) closed the most recent trading day at $24.50, moving +1.66% from the previous trading session.

Are Options Traders Betting on a Big Move in Chemours (CC) Stock?

Investors need to pay close attention to Chemours (CC) stock based on the movements in the options market lately.

Chemours (CC) Gains As Market Dips: What You Should Know

Chemours (CC) closed the most recent trading day at $24.10, moving +0.67% from the previous trading session.